The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global adhesion barriers market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 7% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
An adhesion barrier refers to a liquid-, gel- or film-based medical implant that is used by surgeons to minimize the risks of postoperative adhesion formation between internal organs. It is applied to a layer of tissues before sealing them, thus preventing the formation of scar tissues (adhesion) and separating the tissues from the organs. The synthetic adhesion barriers are manufactured using hyaluronic acid, regenerated cellulose and polyethylene glycol, whereas the natural variants are made using collagen, fibrin and proteins. They are most commonly used in abdominal, orthopedic, gynecological, reconstructive, cardiovascular and urological surgeries.
Significant growth in the healthcare sector and the increasing prevalence of chronic lifestyle diseases, along with the rising geriatric population across the globe, are among the key factors driving the growth of the market. The treatment of various disorders, such as cardiovascular diseases (CVDs), obesity and gastric ailments, require numerous invasive procedures that may have a high risk of postoperative complications, thereby resulting in the increasing utilization of adhesion barriers. This, along with increasing awareness regarding the benefits of using adhesive barriers for postoperative procedures, is providing a boost to the market growth. Post-surgical adhesions are a common complication in surgeries and adhesion barriers play a crucial role in preventing adverse effects, such as impaired organ functioning, bowel obstruction, decreased fertility, difficult re-operation and extreme discomfort. Additionally, various technological advancements, such as the development of sheet- and spray-type adhesion barriers that are more effective and convenient to use during laparoscopic procedures, are acting as another growth-inducing factor. Other factors, including rising healthcare expenditures and increasing cases of sports-related injuries, are projected to drive the market further.
IMARC Group provides an analysis of the key trends in each sub-segment of the global adhesion barriers market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on product, formulation and application.
Breakup by Product:
Breakup by Formulation:
Breakup by Application:
Breakup by Region:
The competitive landscape of the industry has also been examined with some of the key players being Anika Therapeutics Inc., Atrium Medical Corporation, Baxter International, Betatech Medikal, C. R. Bard, FzioMed Inc., Integra Lifesciences, Johnson & Johnson, MAST Biosurgery Inc. and Sanofi, etc.
|Base Year of the Analysis||2020|
|Segment Coverage||Product, Formulation, Application, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Anika Therapeutics Inc., Atrium Medical Corporation, Baxter International, Betatech Medikal, C. R. Bard, FzioMed Inc., Integra Lifesciences, Johnson & Johnson, MAST Biosurgery Inc. and Sanofi|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
Key Questions Answered in This Report:
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at